1) Artlett CM:Inflammasomes in wound healing and fibrosis. J Pathol 229:157-167, 2013
2) De Nardo D, De Nardo CM, Latz E:New insights into mechanisms controlling the NLRP3 inflammasome and its role in lung disease. Am J Pathol 184:42-54, 2014
3) Exner N, Lutz AK, Haass C, et al:Mitochondrial dysfunction in Parkinson's disease:molecular mechanisms and pathophysiological consequences. EMBO J 31:3038-3062, 2012
4) Haffner SM:The metabolic syndrome:Inflammation and diabetes mellitus, and cardiovascular disease. Am J Cardiol 97:3A-11A, 2006
5) Handshin C, Spiegelman BM:The role of exercise and PGC1-α in inflammation and chronic disease. Nature 454:463-469, 2008
6) Hotamisligil GS, Shargill NS, Spiegelman BM:Adipose expression of tumor necrosis factor-α:direct role in obesity-linked insulin resistance. Science 259:87-91, 1993
7) Liu L, Chan C:The role of inflammasome in Alzheimer's disease. Aging Res Rev 19:15C:6-15, 2014
8) Lumeng CN, Saltierl AR:Inflammatory links between obesity and metabolic disease. J Clin Invest 121:2111-2117, 2011
9) Vandanmagsarl B, Youm Y-H, Ravussin A, et al:The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med 17:180-189, 2011
10) Weisberg SP, McCann D, Desai M, et al:Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796-1808, 2003
11) Zhuo Q, Yang W, Chen J, et al:Metabolic syndrome meets osteoarthritis. Nature Rev Rheum 8:729-737, 2012
12) Whitton PS:Inflammation as a causative factor in the aetiology of Parkinson's disease. Br J Pharmacol 150:963-976, 2007